AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Merz Aesthetics Presents Data at the IMCAS World Congress 2020

January 31, 2020 GMT

FRANKFURT, Germany--(BUSINESS WIRE)--Jan 31, 2020--

Merz, a global leader in medical aesthetics, announced today that data on the Merz Aesthetics product portfolio, including Belotero ®, Cellfina ® and Radiesse ® will be featured in oral and poster presentations at the 2020 International Master Course on Aging Science (IMCAS) World Congress, to be held from 30 January to 1 February 2020 in Paris, France.

“This meeting provides a platform for Merz Aesthetics to not only foster education and continuous training but also, to engage in thoughtful industry conversations while connecting with medical aesthetics physicians and fellow industry leaders from around the world,” said Bob Rhatigan, CEO of Merz Aesthetics. “We are grateful that our heritage and innovation in this space allows us to partner with world-renowned medical aesthetic experts, to share research on the diversified Merz Aesthetics product portfolio at the IMCAS World Congress.”

In addition to the poster presentations listed below, Merz Aesthetics is sponsoring the symposium event “Facial Rejuvenation: Interactive Sessions to Level-Up Your Injection Skills”, to be held on Saturday, 1 February at 10.30h – 12.30h, Room Amphi Bleu. The session will be opened by Bob Rhatigan, CEO of Merz Aesthetics and will include treatment insights from four international expert speakers:

Oral Presentations

Independent presentations including data on the Merz Aesthetics portfolio:

What’s new in minimally invasive treatments

Body shaping and cellulite

Biostimulatory fillers

E-Poster Presentations

E-Posters will be available for viewing at the Poster Zone on Level 2, from Thursday, 30 January to Saturday, 1 February 2020.

BOCOUTURE ® Milestone

This year, Merz is also celebrating the ten-year anniversary of BOCOUTURE ® (incobotulinumtoxin A) in Europe. The botulinum toxin is part of the Merz Aesthetics portfolio and has received approval in 15 countries in Europe within the last ten years. A Booth Talk about “BOCOUTURE ® - 10 Years of a Unique Neurotoxin” with Dr. Thomas Rappl will take place Friday, 31 January, 16.00, Booth N° P251.

Copyright © 2019 Merz Pharma GmbH & Co. KGaA. All rights reserved. MERZ, MERZ AESTHETICS and the MERZ logo are registered trademarks of Merz Pharma GmbH & Co. KgaA.

About Merz

Merz is a global, diversified healthcare company based in Frankfurt, Germany. Privately-held for more than 111 years, the company operates in the areas of aesthetics, therapeutics and consumer care and is distinguished by its commitment to innovation, long-term perspective and focus on profitable growth. In fiscal year 2018/19, Merz generated revenue of EUR 1,094 million; the company has a total workforce of 3,213 employees worldwide and a direct presence in 28 countries. More information is available at www.merz.com.

1 Merz supported Investigator Initiated Trials

View source version on businesswire.com:https://www.businesswire.com/news/home/20200131005133/en/

CONTACT: Merz Pharma GmbH & Co. KGaA

Global Communications

Felicia Glatzel

Phone: +49 69-1503-1210

Email:felicia.glatzel@merz.de

KEYWORD: EUROPE GERMANY FRANCE

INDUSTRY KEYWORD: SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL HEALTH MEDICAL DEVICES COSMETICS RETAIL

SOURCE: Merz

Copyright Business Wire 2020.

PUB: 01/31/2020 03:02 AM/DISC: 01/31/2020 03:02 AM

http://www.businesswire.com/news/home/20200131005133/en